Jeff Yass’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMX
SVCM
OM
Jeff Yass's IMMX Position: Q3 2026 in Review
Jeff Yass increased its Immix Biopharma (IMMX) stake by 71% in Q3 2026, buying an estimated $309K and bringing the position to 66,058 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #8908.
Jeff Yass first reported a position in IMMX in Q1 2023 and has held it in 10 quarters since. The position peaked at $4.29M in Q1 2026. 136 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.
- Jeff Yass held 66,058 shares of Immix Biopharma worth $687K as of Q3 2026.
- Jeff Yass bought 27,327 Immix Biopharma shares in Q3 2026, an estimated $309K.
- Immix Biopharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #8908 holding.
- Jeff Yass first reported a position in Immix Biopharma in Q1 2023 and has held it in 10 quarters since.
- Jeff Yass's Immix Biopharma position peaked at $4.29M in Q1 2026.
- 136 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.